Breast Implants

FDA Clears Certain Breast Implant Shell of Cancer Risk

Published in Women's Health Weekly, July 10th, 1995

The U.S. Food and Drug Administration (FDA) says women should not have a certain type of breast implant removed based solely on concern that its polyurethane shell causes cancer.

At issue are polyurethane foam-covered implants filled with silicone gel. Approximately 110,000 women have this type of implant.

In 1991, a chemical in the polyurethane was linked to cancer in laboratory animals. The FDA asked manufacturer Bristol-Myers Squibb to study the risk in women, and with that request, the company immediately stopped selling the implant.

The FDA announced June 29, 1995, that those studies show the risk of cancer from the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1995-07-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry